What is it about?

SDHx dene mutations lead to familial paragangliomatosis. It is now evident that such mutations can cause the occurrence of other solid tumors like renal, intestinal or pituitary tumors

Featured Image

Why is it important?

Although the occurrence of these additional tumors is rare in SDHx mutation carriers, their occurrence, associated to elements of the clinical history or to their histological phenotype, should suggest the presence of a genetic background and lead to the discovery of a familial disease, with a clinical benefit for the patients and their family members.

Perspectives

I enjoyed reviewing the literature and the clinical records of my patient series to give a full perspective of the clinical pictures linked to SDHx mutations

Massimo Mannelli
Universita degli Studi di Firenze

Read the Original

This page is a summary of: DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas, European Journal of Endocrinology, September 2017, Bioscientifica,
DOI: 10.1530/eje-17-0523.
You can read the full text:

Read

Contributors

The following have contributed to this page